三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
图13中国二期临床数据巴托利单抗组跟安慰剂组比较获益显著
图13中国二期临床数据巴托利单抗组跟安慰剂组比较获益显著
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:345KB
图片尺寸:2351*592
同报告图片
/
4
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
所属报告:
和铂医药-首次覆盖:商业化阶段将至研发能力获全球药企背书-220725(49页).pdf
打包全文图表
相关数据
Ph3ORIGIN3研究中Atacicept及安慰剂组受试者第36周uPCR及Gd-IgA1数据
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
收藏
行业数据
2026-03-13
原图定位
查看详情
RC18针对SDESSDAI剔除安慰剂评分下降情况对比其他药物
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
收藏
行业数据
2026-03-13
原图定位
查看详情
地达西尼安全性和安慰剂相当
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
收藏
行业数据
2025-11-24
原图定位
查看详情
部分口服GLP-1类药物的减重效果对比(安慰剂矫正)
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
收藏
行业数据
2025-11-19
原图定位
查看详情
GLP-1RA±amylin类疗法减重效果对比(安慰剂矫正)
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
收藏
行业数据
2025-11-19
原图定位
查看详情
部分GIP-1/GIPR/GCGR靶点药物的减重效果对比(安慰剂矫正)
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
收藏
行业数据
2025-11-19
原图定位
查看详情
图表44校正安慰剂影响后载脂蛋白B变化情况
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
收藏
行业数据
2025-09-28
原图定位
查看详情
Lp(a)抑制剂的疗效:校正安慰剂效应后的Lp(a)变化百分比
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
收藏
行业数据
2025-09-28
原图定位
查看详情
图表43校正安慰剂影响后Lp(a)变化情况
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
收藏
行业数据
2025-09-28
原图定位
查看详情
Lp(a)抑制剂的疗效:校正安慰剂效应后的LDL变化百分比
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
收藏
行业数据
2025-09-28
原图定位
查看详情
nemolizumab2期临床数据显示,12周瘙痒改善情况优异,且1周时较安慰剂改善超20%
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
收藏
行业数据
2025-09-17
原图定位
查看详情
nemolizumab2期临床数据显示,12周瘙痒改善情况优异,且1周时较安慰剂改善超20%
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
收藏
行业数据
2025-09-17
原图定位
查看详情
图表28校正安慰剂影响后Lp(a)变化情况(完整脂蛋
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
收藏
行业数据
2025-08-15
原图定位
查看详情
图表29校正安慰剂影响后Lp(a)变化情况变化情况
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
收藏
行业数据
2025-08-15
原图定位
查看详情
与安慰剂组相比,泰它西普组24周时MG-ADL和QMG评分不同改
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
收藏
行业数据
2025-06-27
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
因二期临床属于研究者发起临床,患者人数较少。同时安慰剂组(没有活性成分)的患者组期待较强,因此拉高 MG-ADL 此类患者自行评估指标的安慰剂效应。在其他两个医生评估的 QMG 以及 IgG 终点可以观察到用药组较安慰剂组更明显的临床获益。
行业数据
原图定位
当前图表所属:
和铂医药-首次覆盖:商业化阶段将至研发能力获全球药企背书-220725(49页).pdf
表9长期使用糖皮质激素副作用
表8不同MG治疗方案优缺点对比
表7重症肌无力患者MGFA分类
表6巴托利单抗国内市场空间可达184亿
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》